$ENDP Endo International (ENDP) Scheduled to Post
Post# of 109
(Total Views: 1031)
Posted On: 05/01/2018 7:28:26 AM
$ENDP Endo International (ENDP) Scheduled to Post Earnings on Tuesday
by - American Banking and Market News
Endo International (NASDAQ:ENDP) (TSE:ENL) is scheduled to be releasing its earnings data before the market opens on Tuesday, May 8th. Analysts expect Endo International to post earnings of $0.55 per share for the quarter. Endo International has set its FY18 guidance at $2.15-2.55 EPS.
Endo International (NASDAQ:ENDP) (TSE:ENL) last posted its quarterly earnings data on Tuesday, February 27th. The company reported $0.77 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.62 by $0.15. The business had revenue of $768.64 million for the quarter, compared to analysts' expectations of $762.29 million. Endo International had a positive return on equity of 81.03% and a negative net margin of 58.68%. The business's revenue was down 38.1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.77 EPS. On average, analysts expect Endo International to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Endo International stock opened at $5.73 on Tuesday. The company has a current ratio of 1.02, a quick ratio of 0.85 and a debt-to-equity ratio of 17.00. The company has a market cap of $1,340.04, a price-to-earnings ratio of 1.56 and a beta of 0.38. Endo International has a fifty-two week low of $5.27 and a fifty-two week high of $14.15.
ENDP has been the topic of a number of analyst reports. Mizuho reissued a "buy" rating and issued a $12.00 price target (down from $14.00) on shares of Endo International in a research report on Wednesday, January 3rd. Leerink Swann initiated coverage on Endo International in a research report on Tuesday, January 2nd. They issued an "outperform" rating and a $12.00 price target on the stock. Cantor Fitzgerald set a $7.00 price target on Endo International and gave the stock a "hold" rating in a research report on Thursday, January 11th. Zacks Investment Research cut Endo International from a "hold" rating to a "sell" rating in a research report on Monday, January 15th. Finally, BidaskClub cut Endo International from a "hold" rating to a "sell" rating in a research report on Thursday, January 11th. Four equities research analysts have rated the stock with a sell rating, sixteen have issued a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company's stock. Endo International currently has a consensus rating of "Hold" and a consensus target price of $9.40.
About Endo International
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.
The views expressed in any and all content distributed by Newstex and its re-distributors (collectively, the "Newstex Authoritative Content"
are solely those of the respective author(s) and not necessarily the views of Newstex or its re-distributors. Stories from such authors are provided "AS IS," with no warranties, and confer no rights. The material and information provided in Newstex Authoritative Content are for general information only and should not, in any respect, be relied on as professional advice. Newstex Authoritative Content is not "read and approved" before it is posted. Accordingly, neither Newstex nor its re-distributors make any claims, promises or guarantees about the accuracy, completeness, or adequacy of the information contained therein or linked to from such content, nor do they take responsibility for any aspect of such content. The Newstex Authoritative Content shall be construed as author-based content and commentary. Accordingly, no warranties or other guarantees are offered as to the quality of the opinions, commentary or anything else appearing in such Newstex Authoritative Content. Newstex and its re-distributors expressly reserve the right to delete stories at its and their sole discretion.
Source: Online Publications (April 30, 2018 - 8:00 PM EDT)
News by QuoteMedia
www.quotemedia.com
by - American Banking and Market News
Endo International (NASDAQ:ENDP) (TSE:ENL) is scheduled to be releasing its earnings data before the market opens on Tuesday, May 8th. Analysts expect Endo International to post earnings of $0.55 per share for the quarter. Endo International has set its FY18 guidance at $2.15-2.55 EPS.
Endo International (NASDAQ:ENDP) (TSE:ENL) last posted its quarterly earnings data on Tuesday, February 27th. The company reported $0.77 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.62 by $0.15. The business had revenue of $768.64 million for the quarter, compared to analysts' expectations of $762.29 million. Endo International had a positive return on equity of 81.03% and a negative net margin of 58.68%. The business's revenue was down 38.1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.77 EPS. On average, analysts expect Endo International to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Endo International stock opened at $5.73 on Tuesday. The company has a current ratio of 1.02, a quick ratio of 0.85 and a debt-to-equity ratio of 17.00. The company has a market cap of $1,340.04, a price-to-earnings ratio of 1.56 and a beta of 0.38. Endo International has a fifty-two week low of $5.27 and a fifty-two week high of $14.15.
ENDP has been the topic of a number of analyst reports. Mizuho reissued a "buy" rating and issued a $12.00 price target (down from $14.00) on shares of Endo International in a research report on Wednesday, January 3rd. Leerink Swann initiated coverage on Endo International in a research report on Tuesday, January 2nd. They issued an "outperform" rating and a $12.00 price target on the stock. Cantor Fitzgerald set a $7.00 price target on Endo International and gave the stock a "hold" rating in a research report on Thursday, January 11th. Zacks Investment Research cut Endo International from a "hold" rating to a "sell" rating in a research report on Monday, January 15th. Finally, BidaskClub cut Endo International from a "hold" rating to a "sell" rating in a research report on Thursday, January 11th. Four equities research analysts have rated the stock with a sell rating, sixteen have issued a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company's stock. Endo International currently has a consensus rating of "Hold" and a consensus target price of $9.40.
About Endo International
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.
The views expressed in any and all content distributed by Newstex and its re-distributors (collectively, the "Newstex Authoritative Content"
are solely those of the respective author(s) and not necessarily the views of Newstex or its re-distributors. Stories from such authors are provided "AS IS," with no warranties, and confer no rights. The material and information provided in Newstex Authoritative Content are for general information only and should not, in any respect, be relied on as professional advice. Newstex Authoritative Content is not "read and approved" before it is posted. Accordingly, neither Newstex nor its re-distributors make any claims, promises or guarantees about the accuracy, completeness, or adequacy of the information contained therein or linked to from such content, nor do they take responsibility for any aspect of such content. The Newstex Authoritative Content shall be construed as author-based content and commentary. Accordingly, no warranties or other guarantees are offered as to the quality of the opinions, commentary or anything else appearing in such Newstex Authoritative Content. Newstex and its re-distributors expressly reserve the right to delete stories at its and their sole discretion. Source: Online Publications (April 30, 2018 - 8:00 PM EDT)
News by QuoteMedia
www.quotemedia.com
(0)
(0)Endo International plc (ENDPQ) Stock Research Links
Engineer by trade & Swing Trader at Heart!
Join Webull today and get up to 75 #FREE stocks!
Get started >> Register with my referral link now>> JOIN HERE NOW
CLICK TO SEE --> Engineer, Design,& Build Packaging Equipment
Join Webull today and get up to 75 #FREE stocks!
Get started >> Register with my referral link now>> JOIN HERE NOW
CLICK TO SEE --> Engineer, Design,& Build Packaging Equipment